Cargando…
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
Immunostimulatory monoclonal antibodies can be given in combinations, hence modulating the activity of 2 or more receptors of the immune system. Some of these combinations have been shown to synergize at the elicitation of therapeutically relevant immune responses in transgenic mice developing spont...
Autores principales: | Morales-Kastresana, Aizea, Labiano, Sara, Gütgemann, Ines, Melero, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091451/ https://www.ncbi.nlm.nih.gov/pubmed/25061546 http://dx.doi.org/10.4161/onci.27812 |
Ejemplares similares
-
Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013) -
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodies
por: Verbrugge, Inge, et al.
Publicado: (2012) -
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2014) -
High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies
por: Binder, David C, et al.
Publicado: (2013) -
Trial watch: Immunostimulatory cytokines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014)